Hypermagnesemia: Causes and Clinical Manifestations
Hypermagnesemia most commonly occurs in the obstetric setting from IV magnesium sulfate treatment for preeclampsia/eclampsia, or in patients with renal failure who are taking magnesium-containing medications (antacids or laxatives), and presents with progressive neuromuscular depression ranging from muscular weakness and drowsiness to bradycardia, respiratory failure, and cardiac arrest. 1
Definition and Normal Range
Hypermagnesemia is defined as serum magnesium concentration >2.2 mEq/L (normal range: 1.3-2.2 mEq/L) 2.
Primary Causes
Most Common Clinical Scenarios:
Obstetric patients: Severe hypermagnesemia occurs most frequently in pregnant women receiving IV magnesium sulfate for preeclampsia or eclampsia 1. Iatrogenic overdose is particularly likely if the patient becomes oliguric 2. Magnesium levels of 2.5-5 mmol/L cause ECG changes (prolonged PR, QRS, QT intervals), while levels of 6-10 mmol/L produce AV nodal block, bradycardia, hypotension, and cardiac arrest 2.
Renal failure with magnesium intake: Hypermagnesemia is uncommon in the general population because healthy kidneys can increase fractional excretion to nearly 100% when the magnesium threshold is exceeded 3. However, patients with renal insufficiency who ingest magnesium-containing products are at high risk 2, 4, 5. Critically, severe hypermagnesemia can occur even with mild-to-moderate renal impairment (creatinine <3.6 mg/dl), not just end-stage renal disease 5.
Specific Risk Factors:
- Magnesium-containing medications: Antacids (e.g., Maalox, Mylanta) or cathartics/laxatives (magnesium oxide, magnesium citrate) 2, 4, 5, 6
- Bowel disorders enhancing absorption: Active ulcer disease, gastritis, colitis, perforated viscus, massive gastric dilatation, or stercoral colitis 5, 7
- Elderly patients: Particularly vulnerable, even without severe renal failure 5
- Continuous renal replacement therapy (CRRT): Can cause hypermagnesemia when magnesium-free dialysate is not used 8
Signs and Symptoms by Severity
Neurological Manifestations:
Early signs (magnesium 2.5-5 mmol/L):
Severe signs (magnesium >6 mmol/L):
- Depressed level of consciousness progressing to coma 2, 9
- Flaccid muscle paralysis 3
- Ophthalmoplegia (bilateral eye movement paralysis) and ptosis 10
- Respiratory depression and hypoventilation 2, 5
- Respiratory failure 9
Cardiovascular Manifestations:
- Vasodilation and hypotension 2, 5
- Bradycardia 2, 5
- ECG abnormalities: prolonged PR, QRS, and QT intervals 2, 5
- AV nodal conduction block 2
- Cardiac arrhythmias 2
- Cardiorespiratory arrest 2
Other Manifestations:
- Nausea and vomiting 3
- Facial flushing 3
- Ileus 3
- Severe hypocalcemia (range 5.7-7.4 mg/dl) more profound than expected from hypoalbuminemia or renal failure alone 5
- Low anion gap (range -2 to 9) 5
Critical Clinical Pitfalls
Most striking finding: Hypermagnesemia was clinically unsuspected in 6 of 8 cases in one series despite obvious cardiovascular and neurological sequelae 5. The nonspecific nature of symptoms makes diagnosis challenging 9.
Do not assume severe renal failure is required: Hypermagnesemia can develop with only mild-to-moderate renal impairment when combined with magnesium intake and bowel disorders 5.
Elderly patients are particularly vulnerable: Even with "normal" doses of magnesium-containing products, elderly patients with bowel disease can develop severe toxicity 5.
Psychiatric patients on chronic magnesium oxide: Long-term MgO administration for constipation carries significant risk, with female sex, higher daily doses, and elevated creatinine being key risk factors 6.